{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:38:56Z","timestamp":1785494336109,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00120-025-02760-w","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:53:40Z","timestamp":1770368020000},"page":"198-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aktuelle Diagnostik und Therapie des Peniskarzinoms","Current diagnostics and treatment of penile cancer"],"prefix":"10.1007","volume":"65","author":[{"given":"D\u00e9sir\u00e9e Louise","family":"Dr\u00e4ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Protzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"1","key":"2760_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.juro.2013.07.088","volume":"191","author":"RS Djajadiningrat","year":"2014","unstructured":"Djajadiningrat\u00a0RS, Graafland\u00a0NM, van Werkhoven\u00a0E et\u00a0al (2014) Contemporary management of regional nodes in penile cancer-improvement of survival? J\u00a0Urol 191(1):68\u201373","journal-title":"J Urol"},{"key":"2760_CR2","unstructured":"Vanthoor J, Thomas A, Tsaur I, Albersen M (2019) in collaboration with the European Reference Network for rare urogenital diseases and complex conditions (eUROGEN). Making surgery safer by centralization of care: impact of case load in penile cancer. World J Urol: 1\u20136"},{"key":"2760_CR3","volume-title":"Textbook of penile cancer","author":"P Hadway","year":"2016","unstructured":"Hadway\u00a0P, Malone\u00a0P (2016) Muneer\u00a0A. Management of penile cancer using penile-preserving techniques. In: Muneer\u00a0A, Ayrya\u00a0M, Horenblas\u00a0S (Hrsg) Textbook of penile cancer, 2.\u00a0Aufl. Springer, London:","edition":"2"},{"key":"2760_CR4","unstructured":"(2020) https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/peniskarzinom\/"},{"key":"2760_CR5","unstructured":"(2025) http:\/\/uroweb.org\/guideline\/penile-cancer\/"},{"key":"2760_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3238\/arztebl.2018.0646","volume":"115","author":"OW Hakenberg","year":"2018","unstructured":"Hakenberg\u00a0OW, Dr\u00e4ger\u00a0DL, Erbersdobler\u00a0A, Naumann\u00a0CM, J\u00fcnemann\u00a0KP, Protzel\u00a0C (2018) The diagnosis and treatment of penile cancer. Dtsch \u00c4rztebl Int 115:646\u2013652. https:\/\/doi.org\/10.3238\/arztebl.2018.0646","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"2","key":"2760_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.7314\/APJCP.2014.15.2.599","volume":"15","author":"R Takiar","year":"2014","unstructured":"Takiar\u00a0R, Kumar\u00a0S (2014) Pattern of reproductive cancers in India. Asian Pac J Cancer Prev 15(2):599\u2013603","journal-title":"Asian Pac J Cancer Prev"},{"key":"2760_CR8","volume-title":"Textbook of penile cancer","author":"S Ottenhof","year":"2016","unstructured":"Ottenhof\u00a0S, Bleeker\u00a0M, Heideman\u00a0D et\u00a0al (2016) Etiology of penile cancer. In: Muneer\u00a0A, Ayrya\u00a0M, Horenblas\u00a0S (Hrsg) Textbook of penile cancer, 2.\u00a0Aufl. Springer, London","edition":"2"},{"issue":"5","key":"2760_CR9","first-page":"361","volume":"25","author":"JS Barnholtz-Sloan","year":"2007","unstructured":"Barnholtz-Sloan\u00a0JS, Maldonado\u00a0JL, Pow-sang\u00a0J, Guiliano\u00a0AR (2007) Incidence trends in primary malignant penile cancer. Urol Oncol Seminars Orig Investig 25(5):361\u2013367","journal-title":"Urol Oncol Seminars Orig Investig"},{"issue":"2","key":"2760_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.juro.2014.08.087","volume":"193","author":"RS Djajadiningrat","year":"2015","unstructured":"Djajadiningrat\u00a0RS, Jordanova\u00a0ES, Kroon\u00a0BK et\u00a0al (2015) Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome. J\u00a0Urol 193(2):526\u2013531","journal-title":"J Urol"},{"issue":"1","key":"2760_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.euf.2018.09.010","volume":"5","author":"B Schlenker","year":"2019","unstructured":"Schlenker\u00a0B, Schneede\u00a0P (2019) The role of human papilloma virus in penile cancer prevention and new therapeutic agents. Eur Urol Focus 5(1):42\u201345","journal-title":"Eur Urol Focus"},{"issue":"10","key":"2760_CR12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/infdis\/jis228","volume":"205","author":"M Blomberg","year":"2012","unstructured":"Blomberg\u00a0M, Friis\u00a0S, Munk\u00a0C, Bautz\u00a0A, Kjaer\u00a0SK (2012) Genital warts and risk of cancer: a\u00a0Danish study of nearly 50 000 patients with genital warts. J\u00a0Infect Dis 205(10):1544\u20131553","journal-title":"J Infect Dis"},{"issue":"1","key":"2760_CR13","first-page":"53.e1","volume":"32","author":"A Flaherty","year":"2014","unstructured":"Flaherty\u00a0A, Kim\u00a0T, Giuliano\u00a0A et\u00a0al (2014) Implications for human papillomavirus in penile cancer. Urol Oncol Seminars Orig Investig 32(1):53.e1\u201353.e8","journal-title":"Urol Oncol Seminars Orig Investig"},{"issue":"2","key":"2760_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/0019-5154.152501","volume":"60","author":"CB Bunker","year":"2015","unstructured":"Bunker\u00a0CB, Shim\u00a0TN (2015) Male genital lichen schlerosus. Indian J Dermatol 60(2):111\u2013117","journal-title":"Indian J Dermatol"},{"issue":"8","key":"2760_CR15","first-page":"1097","volume":"22","author":"NL Larke","year":"2011","unstructured":"Larke\u00a0NL, Thomas\u00a0SL, dos\u00a0SSI, Weiss\u00a0HA (2011) Male circumcision and penile cancer: a\u00a0systematic review and meta-analysis. Cancer Causes Control 22(8):1097\u20131110","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2760_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/ijc.21009","volume":"116","author":"JR Daling","year":"2005","unstructured":"Daling\u00a0JR, Madeleine\u00a0MM, Johnson\u00a0LG et\u00a0al (2005) Penile cancer: importance of circumcision, human papillomavirus and smoking inin situ and invasive disease. Int J Cancer 116(4):606\u2013616","journal-title":"Int J Cancer"},{"issue":"1","key":"2760_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12894-015-0007-8","volume":"15","author":"IDB de Sousa","year":"2015","unstructured":"de Sousa\u00a0IDB, Vidal\u00a0FCB, Vidal\u00a0BJPC, de Mello\u00a0GCF, do Desterro Soares Brand\u00e3o Nascimen\u00a0M, Brito\u00a0LMO (2015) Prevalence of human papillomavirus in penile malignant tumors: viral genotyping and clinical aspects. BMC Urol 15(1):13","journal-title":"BMC Urol"},{"issue":"29","key":"2760_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.7748\/ns2013.03.27.29.50.e6135","volume":"27","author":"B Turner","year":"2013","unstructured":"Turner\u00a0B, Drudge-Coates\u00a0L, Henderson\u00a0S (2013) Penile cancer: diagnosis, clinical features and management. Nurs Stand 27(29):50\u201357","journal-title":"Nurs Stand"},{"key":"2760_CR19","volume-title":"Textbook of penile cancer","author":"H Alnajjar","year":"2016","unstructured":"Alnajjar\u00a0H, Malone\u00a0P (2016) Diagnosis and staging of penile cancer. In: Muneer\u00a0A, Arya\u00a0M, Horenblas\u00a0S (Hrsg) Textbook of penile cancer, 2.\u00a0Aufl. Springer, London:","edition":"2"},{"issue":"5","key":"2760_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/00365599.2012.677473","volume":"46","author":"E Skeppner","year":"2012","unstructured":"Skeppner\u00a0E, Andersson\u00a0SO, Johansson\u00a0JE, Windahl\u00a0T (2012) Initial symptoms and delay in patients with penile carcinoma. Scand J Urol Nephrol 46(5):319\u2013325","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"2760_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MOU.0000000000000585","volume":"29","author":"HM de Vries","year":"2019","unstructured":"de Vries\u00a0HM, Brouwer\u00a0OR, Heijmink\u00a0S, Horenblas\u00a0S, Vegt\u00a0E (2019) Recent developments in penile cancer imaging. Curr Opin Urol 29(2):150\u2013155","journal-title":"Curr Opin Urol"},{"key":"2760_CR22","volume-title":"Textbook of penile cancer","author":"A Kirkham","year":"2016","unstructured":"Kirkham\u00a0A (2016) Radiological imaging in penile cancer. In: Muneer\u00a0A, Ayrya\u00a0M, Horenblas\u00a0S (Hrsg) Textbook of penile cancer, 2.\u00a0Aufl. Springer, London:","edition":"2"},{"issue":"9","key":"2760_CR23","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1464-410X.2004.05153.x","volume":"94","author":"P Pietrzak","year":"2004","unstructured":"Pietrzak\u00a0P, Corbishley\u00a0C, Watkin\u00a0N (2004) Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int 94(9):1253\u20131257","journal-title":"BJU Int"},{"key":"2760_CR24","volume-title":"Atlas of male genitourethral surgery. The illustrated guide","author":"S Horenblas","year":"2013","unstructured":"Horenblas\u00a0S, Malone\u00a0PRM (2013) Surgical treatment of penile cancer. In: Muneer\u00a0A, Ayrya\u00a0M, Jordan\u00a0GH (Hrsg) Atlas of male genitourethral surgery. The illustrated guide. John Wiley, Chichester"},{"issue":"6","key":"2760_CR25","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.eururo.2011.02.009","volume":"59","author":"P Branney","year":"2011","unstructured":"Branney\u00a0P, Witty\u00a0K, Eardley\u00a0I (2011) Patients\u2019 experiences of penile cancer. Eur Urol 59(6):959\u2013961","journal-title":"Eur Urol"},{"key":"2760_CR26","volume-title":"Textbook of penile cancer","author":"G Garaffa","year":"2016","unstructured":"Garaffa\u00a0G, Christopher\u00a0N, Ralph\u00a0D (2016) Phallic reconstruction following penile cancer surgery In. In: Muneer\u00a0A, Ayrya\u00a0M, Horenblas\u00a0S (Hrsg) Textbook of penile cancer, 2.\u00a0Aufl. Springer, London:","edition":"2"},{"key":"2760_CR27","volume-title":"Textbook of penile cancer","author":"S Ottenhof","year":"2016","unstructured":"Ottenhof\u00a0S, Graafland\u00a0N (2016) Horenblas\u00a0S. Management of lymph nodes. In: Muneer\u00a0A, Ayrya\u00a0M, Horenblas\u00a0S (Hrsg) Textbook of penile cancer, 2.\u00a0Aufl. Springer, London:","edition":"2"},{"issue":"2","key":"2760_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jso.20414","volume":"93","author":"D Pandey","year":"2006","unstructured":"Pandey\u00a0D, Mahajan\u00a0V, Kannan\u00a0RR (2006) Prognostic factors in node-positive carcinoma of the penis. J\u00a0Surg Oncol 93(2):133\u2013138","journal-title":"J Surg Oncol"},{"issue":"4","key":"2760_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","volume":"191","author":"G Lughezzani","year":"2014","unstructured":"Lughezzani\u00a0G et\u00a0al (2014) The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a\u00a0single institution experience. J\u00a0Urol 191(4):977\u2013982","journal-title":"J Urol"},{"issue":"3","key":"2760_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-5347(17)36126-8","volume":"149","author":"S Horenblas","year":"1993","unstructured":"Horenblas\u00a0S et\u00a0al (1993) Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J\u00a0Urol 149(3):492\u2013497","journal-title":"J Urol"},{"issue":"5","key":"2760_CR31","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0022-5347(17)38069-2","volume":"146","author":"FH Dexeus","year":"1991","unstructured":"Dexeus\u00a0FH, Logothetis\u00a0CJ, Sella\u00a0A, Amato\u00a0R, Kilbourn\u00a0R, Fitz\u00a0K, Striegel\u00a0A (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J\u00a0Urol 146(5):1284\u20131287","journal-title":"J Urol"},{"issue":"6","key":"2760_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","volume":"161","author":"GP Haas","year":"1999","unstructured":"Haas\u00a0GP, Blumenstein\u00a0BA, Gagliano\u00a0RG, Russell\u00a0CA, Rivkin\u00a0SES, Culkin\u00a0DJ, Wolf\u00a0M, Crawford\u00a0ED (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a\u00a0Southwest Oncology Group study. J\u00a0Urol 161(6):1823\u20131825","journal-title":"J Urol"},{"issue":"3","key":"2760_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1756287212441235","volume":"4","author":"OW Hakenberg","year":"2012","unstructured":"Hakenberg\u00a0OW, Protzel\u00a0C (2012) Chemotherapy in penile cancer. Ther Adv Urol 4(3):133\u2013138","journal-title":"Ther Adv Urol"},{"key":"2760_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1055\/a-2224-4999","volume":"45","author":"OW Hakenberg","year":"2024","unstructured":"Hakenberg\u00a0OW, Dr\u00e4ger\u00a0DL (2024) Systemtherapie des Peniskarzinoms \u2013 neue Konzepte? Neue Erfolge. Tumordiagn U Ther 45:44\u201351","journal-title":"Tumordiagn U Ther"},{"issue":"12","key":"2760_CR35","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00120-009-2108-z","volume":"48","author":"C Protzel","year":"2009","unstructured":"Protzel\u00a0C, Ruppin\u00a0S, Milerski\u00a0S, Klebingat\u00a0KJ, Hakenberg\u00a0OW (2009) The current state of the art of chemotherapy of penile cancer: results of a\u00a0nationwide survey of German clinics. Urologe\u00a0A 48(12):1495\u20131498","journal-title":"Urologe A"},{"issue":"3","key":"2760_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","volume":"55","author":"D Pizzocaro","year":"2009","unstructured":"Pizzocaro\u00a0D, Nicolai\u00a0N, Milani\u00a0A (2009) Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 55(3):546\u2013551","journal-title":"Eur Urol"},{"issue":"4","key":"2760_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ajur.2022.03.006","volume":"9","author":"V Joshi","year":"2022","unstructured":"Joshi\u00a0V, Chabha\u00a0J, Chahoud\u00a0J (2022) Penile cancer: Updates in systemic therapy. Asian J Urol 9(4):374\u2013388","journal-title":"Asian J Urol"},{"issue":"24","key":"2760_CR38","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro\u00a0LC, Williams\u00a0DL, Daliani\u00a0D, Williams\u00a0MB, Osai\u00a0W, Kincaid\u00a0M, Wen\u00a0S, Thall\u00a0PF, Pettaway\u00a0CA (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a\u00a0phase\u00a0II study. J\u00a0Clin Oncol 28(24):3851\u20133857","journal-title":"J Clin Oncol"},{"issue":"6","key":"2760_CR39","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/jnci\/djae034","volume":"116","author":"KM Rose","year":"2024","unstructured":"Rose\u00a0KM, Pham\u00a0R, Zacharias\u00a0NM, Ionescu\u00a0F, Paravathaneni\u00a0M, Marchetti\u00a0KA, Sanchez\u00a0D et\u00a0al (2024) Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study. J\u00a0Natl Cancer Inst 116(6):966\u2013973","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2760_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","volume":"54","author":"JP Leijte","year":"2008","unstructured":"Leijte\u00a0JP, Kirrander\u00a0P, Antonini\u00a0N, Windahl\u00a0T, Horenblas\u00a0S (2008) Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a\u00a0two-centre analysis of 700 patients. Eur Urol 54(1):161\u2013168","journal-title":"Eur Urol"},{"issue":"11","key":"2760_CR41","doi-asserted-by":"publisher","first-page":"496.e17","DOI":"10.1016\/j.urolonc.2015.05.008","volume":"33","author":"P Sharma","year":"2015","unstructured":"Sharma\u00a0P, Djajadiningrat\u00a0R, Zargar-Shoshtari\u00a0K, Catanzaro\u00a0M, Zhu\u00a0Y, Nicolai\u00a0N, Horenblas\u00a0S, Spiess\u00a0PE (2015) Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a\u00a0multi-institutional study. Urol Oncol 33(11):496.e17\u2013496.e23","journal-title":"Urol Oncol"},{"issue":"5","key":"2760_CR42","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.clgc.2017.02.002","volume":"15","author":"A Necchi","year":"2017","unstructured":"Necchi\u00a0A, Pond\u00a0GR, Raggi\u00a0D, Ottenhof\u00a0SR, Djajadiningrat\u00a0RS, Horenblas\u00a0S, Khoo\u00a0V, Hakenberg\u00a0OW, Draeger\u00a0D, Protzel\u00a0C (2017) Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a\u00a0Multicenter Analysis. Clin Genitourin Cancer 15(5):548\u2013555.e3","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"2760_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/bju.14013","volume":"121","author":"A Necchi","year":"2018","unstructured":"Necchi\u00a0A, Vullo\u00a0SL, Perrone\u00a0F, Raggi\u00a0D, Giannatempo\u00a0P, Calareso\u00a0G et\u00a0al (2018) First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase\u00a02\u00a0study. BJU Int 121(3):348\u2013356","journal-title":"BJU Int"},{"issue":"11","key":"2760_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/jpm13111623","volume":"13","author":"K Rouvinov","year":"2023","unstructured":"Rouvinov\u00a0K et\u00a0al (2023) Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A\u00a0Real-World Experience. J\u00a0Pers Med 13(11):162","journal-title":"J Pers Med"},{"issue":"12","key":"2760_CR45","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/jnci\/djad155","volume":"115","author":"T El Zarif","year":"2023","unstructured":"El Zarif\u00a0T et\u00a0al (2023) Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors. J\u00a0Natl Cancer Inst 115(12):1605\u20131615","journal-title":"J Natl Cancer Inst"},{"key":"2760_CR46","unstructured":"Del Muro XG et\u00a0al (2024) Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase\u00a02 ORPHEUS Study. Eur Urol Oncol (24):S2588\u20139311"},{"issue":"31","key":"2760_CR47","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1200\/JCO.22.02894","volume":"41","author":"HM de Vires","year":"2023","unstructured":"de Vires\u00a0HM et\u00a0al (2023) Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A\u00a0Phase\u00a0II Trial. J\u00a0Clin Oncol 41(31):4872\u20134880","journal-title":"J Clin Oncol"},{"issue":"2","key":"2760_CR48","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/bju.15828","volume":"131","author":"R Yan","year":"2023","unstructured":"Yan\u00a0R et\u00a0al (2023) First-line programmed death receptor\u20111 (PD-1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum-based chemotherapy, for stage\u00a0IV penile cancer. BJU Int 131(2):198\u2013207","journal-title":"BJU Int"},{"key":"2760_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.humpath.2023.10.003","volume":"142","author":"B Tekin","year":"2023","unstructured":"Tekin\u00a0B et\u00a0al (2023) Assessment of PD-L1, TROP2, and nectin\u20114 expression in penile squamous cell carcinoma. Hum Pathol 142:42\u201350","journal-title":"Hum Pathol"},{"issue":"22","key":"2760_CR50","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.3390\/ijms242216109","volume":"24","author":"CC Fahey","year":"2023","unstructured":"Fahey\u00a0CC et\u00a0al (2023) Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin. Int J Mol Sci 24(22):16109","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2760_CR51","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/cancers16112086","volume":"16","author":"LC Pagliaro","year":"2024","unstructured":"Pagliaro\u00a0LC, Tekin\u00a0B, Gupta\u00a0S, Hernandez\u00a0LH (2024) Therapeutic Targets in Advanced Penile Cancer: From Bench to Bedside. Cancers 16(11):2086. https:\/\/doi.org\/10.3390\/cancers16112086","journal-title":"Cancers"},{"issue":"7","key":"2760_CR52","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s00120-025-02605-6","volume":"64","author":"DL Dr\u00e4ger","year":"2025","unstructured":"Dr\u00e4ger\u00a0DL (2025) Innovative systemic treatment approaches for advanced penile cancer. Urologie 64(7):700\u2013703. https:\/\/doi.org\/10.1007\/s00120-025-02605-6","journal-title":"Urologie"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02760-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-025-02760-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02760-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:03:31Z","timestamp":1770822211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-025-02760-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2760"],"URL":"https:\/\/doi.org\/10.1007\/s00120-025-02760-w","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"C. Protzel: A. Finanzielle Interessen: C. Protzel gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B. Nichtfinanzielle Interessen: Chefarzt der Klinik f\u00fcr Urologie, Helios Kliniken Schwerin | Mitgliedschaften: DGU, DKG, EAU, SIU.\nD. L. Dr\u00e4ger: A. Finanzielle Interessen: D. L. Dr\u00e4ger gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B. Nichtfinanzielle Interessen: Ober\u00e4rztin der Universit\u00e4tsmedizin Rostock | Mitgliedschaften: DGU, DKG, PSO, AUO","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}